PIM1 and idiopathic pulmonary fibrosis: Together, our data strongly suggest that activation of PIM1/NFATc1 pathways in aging may perpetuate fibroblast activation and impair fibrosis resolution, and that its pharmacological inhibition may facilitate fibrosis resolution in IPF lungs.